Missed a Dose of Ozempic, Wegovy, Mounjaro or Zepbound? What the Labels Say

It is Thursday, your shot day was Monday, and you forgot. What now?

The answer is in your label, and it is not the same as the answer in someone else’s. There are four different structures across the GLP-1 drugs sold in the US, and two of the biggest brands measure from opposite ends of the same gap. Ozempic’s rule is measured from the dose you missed — how many days since. Wegovy’s is measured from the dose that is coming — how many days until. That is not a stylistic difference. On some calendar days the two labels give opposite answers for the same molecule.

Here is what each FDA-approved label says. This is a description of the labels, not advice about your dose. The labels themselves send you to a healthcare provider for anything beyond a single missed dose.

What is the missed-dose rule for every GLP-1, in one table?

Drug	Missed-dose rule	Minimum gap between doses	Reescalation trigger
Ozempic (semaglutide, weekly)	Take within 5 days of the missed dose; after that, skip it	2 days (>48 hours)	None in the label
Wegovy injection (semaglutide, weekly)	Take it if the next dose is more than 2 days away; otherwise skip	2 days (48 hours)	2 or more consecutive doses missed
Wegovy HD 7.2 mg	Same as Wegovy injection	2 days	2 or more consecutive doses
Zepbound (tirzepatide, weekly)	Take within 4 days (96 hours); after that, skip it	3 days (72 hours)	None in the label
Mounjaro (tirzepatide, weekly)	Take within 4 days (96 hours); after that, skip it	3 days (72 hours)	None in the label
Trulicity (dulaglutide, weekly)	Take it if at least 3 days (72 hours) remain before the next dose; otherwise skip	3 days	None in the label
Rybelsus / Ozempic tablets (oral semaglutide, daily)	Skip it; take the next dose the following day	One tablet per day	None in the label
Wegovy tablets (oral semaglutide, daily)	Skip it; take the next dose the following day	One tablet per day	None in the label
Foundayo (orforglipron, daily)	Take it as soon as possible; never two in one day	One tablet per day	7 or more consecutive doses missed
Saxenda / Victoza (liraglutide, daily)	Skip it; resume with the next scheduled daily dose	One dose per day	More than 3 days since the last dose

Sources: the Ozempic [1][7], Wegovy [2], Zepbound [3], Trulicity [4], Saxenda [5] and Foundayo [6] labels.

Why are Ozempic and Wegovy written differently?

They contain the same molecule. They are not written the same way, and the difference is real.

Ozempic measures elapsed time since the dose you missed. The label says: “If a dose is missed, administer OZEMPIC as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once-weekly dosing schedule” [1].

Wegovy measures remaining time until the dose that is coming. Section 2.4 says: “If one dose of WEGOVY injection is missed and the next scheduled dose is: more than 2 days away, administer WEGOVY injection as soon as possible. Less than 2 days away, do not administer the WEGOVY injection dose. Resume dosing on the regularly scheduled day of the week” [2].

Work through Thursday, with a Monday shot day. On Ozempic, three days have passed, which is inside five, so the label’s answer is to take it as soon as possible. On Wegovy, the next scheduled dose is Monday, which is four days away — more than two — so the answer is also to take it as soon as possible.

Now try Saturday. On Ozempic, five days have passed, and the label’s window is “as soon as possible within 5 days after the missed dose” — so Saturday is still inside it, and the label’s answer is to take it. On Wegovy, the next dose is Monday, two days away, which is not more than two days, so the label’s answer is to skip it and resume Monday.

Same molecule, same calendar day, opposite answers. This is why “I looked it up” is not a substitute for looking up your product — and why, if the two rules seem to disagree for the box in your hand, the rule that governs is the one printed in your own label.

What about Zepbound and Mounjaro?

Tirzepatide is the tighter of the two families, and both brands say the same thing.

The Zepbound label: “If a dose is missed, instruct patients to administer ZEPBOUND as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day” [3]. The Mounjaro label is word-for-word identical with its own product name [1].

The Mounjaro Medication Guide puts the constraint in the way that is most useful to remember: “If you miss a dose of MOUNJARO, take the missed dose as soon as possible within 4 days (96 hours) after the missed dose. If more than 4 days have passed, skip the missed dose and take your next dose on the regularly scheduled day. Do not take 2 doses of MOUNJARO within 3 days of each other” [1].

The Zepbound Medication Guide carries the identical sentence with its own product name: “Do not take 2 doses of ZEPBOUND within 3 days (72 hours) of each other” [3].

That last sentence is the one that binds. A late dose plus a scheduled dose can collide, and 72 hours is the floor.

Can I move my injection day?

Yes, and every weekly label says so. What varies is the minimum interval [1][2][3][4]:

• Ozempic: “The day of weekly administration can be changed if necessary as long as the time between two doses is at least 2 days (>48 hours).”
• Wegovy: “If you need to change the day of the week, you may do so as long as your last dose of WEGOVY was given 2 or more days before.”
• Zepbound and Mounjaro: the day can be changed “as long as the time between the two doses is at least 3 days (72 hours).”
• Trulicity: the same 3-day / 72-hour framing.

Two practical notes. First, these are hour counts, not clock times, so travel across time zones does not by itself break the schedule. Second, a change in the day is still a change in your treatment routine, and the labels say it can be done “if necessary” — they are describing a limit, not recommending a habit.

What if I have missed more than one dose?

Here the labels become more cautious, and only three drugs address it at all.

Wegovy injection. “If 2 or more consecutive doses of WEGOVY injection are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions” [2]. That is an instruction to the prescriber. The Medication Guide’s version for patients is: “If you miss doses of WEGOVY for 2 or more consecutive weeks, contact your healthcare provider to talk about how to restart your treatment” [2].

Foundayo (orforglipron). “If 7 or more consecutive doses are missed, reinitiate dosage escalation at a lower dosage to reduce the risk of gastrointestinal adverse reactions” [6]. The Medication Guide: “If you miss taking FOUNDAYO for 7 or more days in a row, call your healthcare provider to talk about how to restart your treatment” [6].

Liraglutide (Saxenda). “If more than 3 days have elapsed since the last SAXENDA dose, reinitiate SAXENDA at 0.6 mg daily and follow the dose escalation schedule” [5]. Liraglutide is a daily drug, so three days off is a short gap by weekly-drug standards, and the restart takes it all the way back to the starting dose.

Ozempic, Zepbound, Mounjaro and Trulicity carry no reescalation instruction in their missed-dose sections. That is not the same as saying a long gap has no consequences — it means the labels do not give a rule, and the decision belongs to your prescriber.

In every one of these cases, the label names a prescriber, not a self-service answer. We are not going to tell you what dose to restart at, and neither does the Medication Guide.

What about the pills?

The oral products split cleanly into two rules.

Oral semaglutide — Rybelsus, Ozempic tablets and Wegovy tablets — all say the same thing: “If a dose is missed, skip the missed dose and take the next dose the following day” [1][2]. No catch-up. Never more than one tablet per day.

There is a reason this rule is stricter than the injections’. Oral semaglutide has to be taken on an empty stomach in the morning with up to 4 ounces of water and nothing else, followed by at least 30 minutes before eating, drinking anything else, or taking other oral medicines [1][2]. A “catch-up” dose in the afternoon would not meet the conditions the drug needs to be absorbed, so the label does not offer one.

Foundayo (orforglipron) works differently, and this is one of its selling points. It can be taken with or without food, at any time of day, with no water restriction [6]. So a missed dose can simply be taken when you remember it: “If a dose is missed, instruct patients to take the dose as soon as possible” and “advise patients not to double up the next dose” [6]. The Medication Guide adds: “Do not take 2 doses of FOUNDAYO in the same day.”

What happens if you take a dose too close to the last one?

The labels set the minimum interval but say nothing about what happens if it is violated. We are not going to fill that gap with speculation.

What the labels do address is overdose generally. The Medication Guides direct anyone who has taken too much to call their healthcare provider or the Poison Help line at 1-800-222-1222, or go to the nearest hospital emergency room. The Wegovy guide describes what an overdose may cause: “severe nausea, severe vomiting and severe low blood sugar” [2]. The Mounjaro guide carries the same referral [1].

If you think you have doubled up, that is a phone call, not a wait-and-see.

Why do the windows differ at all?

Mostly because the drugs clear the body at different rates, which is a pharmacology question rather than a how-to one — but two label facts are worth carrying.

Semaglutide is long-acting. The Wegovy label notes that semaglutide is present in the body “for about 5 to 7 weeks after the last injectable dose of 2.4 mg or 7.2 mg or oral dose of 25 mg” [2]. That is why a single missed weekly dose is not the emergency people fear, and why the labels can afford a multi-day catch-up window.

Liraglutide is daily and much shorter-acting, which is why its rule is the strictest on the list: skip the missed day entirely, never double, and restart from the beginning after three days off [5].

How do I stop missing doses?

The labels themselves offer one tool. The Zepbound Instructions for Use ends with a Medication Calendar: “Use ZEPBOUND 1 time a week. Write the day of the week you choose to inject. Inject on this day each week,” with spaces to write four dates [3].

Beyond that, the practical approaches people use — a recurring phone alarm, injecting on a fixed day tied to a routine, writing the date on the carton when you open it — are not label content and we will not dress them up as such. But there is one label-adjacent habit worth the effort: multi-dose devices already require you to track a date. A Wegovy FlexTouch has a 56-day in-use clock, a Zepbound KwikPen a 30-day one. Writing the first-use date on the carton serves both purposes at once.

What this article does not do

It does not tell you what to do about your own missed dose, and it deliberately does not name a restart dose for anyone.

Every reescalation instruction in every label above is written to a prescriber. Both the Wegovy and Foundayo Medication Guides tell patients who have missed a run of doses to contact their healthcare provider. That is the correct answer, and it is the label’s answer, not ours.

What this article is for is knowing which rule applies to you before you call — so the conversation starts from the right place.

Sources

1. Novo Nordisk. OZEMPIC (semaglutide) injection — US Prescribing Information, Medication Guide and Instructions for Use, June 2026; and Eli Lilly and Company, MOUNJARO (tirzepatide) injection — US Prescribing Information and Medication Guide, January 2026. https://www.novo-pi.com/ozempic.pdf
2. Novo Nordisk. WEGOVY (semaglutide) injection and WEGOVY (semaglutide) tablets — US Prescribing Information and Medication Guide, June 2026. https://www.novo-pi.com/wegovy.pdf
3. Eli Lilly and Company. ZEPBOUND (tirzepatide) injection — US Prescribing Information, Section 2.3 Recommendations Regarding Missed Dose, and Instructions for Use. https://uspl.lilly.com/zepbound/zepbound.html
4. DailyMed. TRULICITY — dulaglutide injection, solution, label record. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=463050bd-2b1c-40f5-b3c3-0a04bb433309
5. US Food and Drug Administration / Novo Nordisk. SAXENDA (liraglutide) injection — US Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/206321s016lbl.pdf
6. US Food and Drug Administration / Eli Lilly and Company. FOUNDAYO (orforglipron) tablets — US Prescribing Information, Section 2.3, April 2026, and Medication Guide, July 2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220934Orig1s000lbl.pdf
7. DailyMed. OZEMPIC — semaglutide injection, solution, label record. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79